Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.78

0.0%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (3011)	7/14/2010 2:40:30 PM
From: Jibacoa	Read Replies (1) of 3722

ARNA is continuing its UT for 2nd day on a roll after going through the resistance at the $4 level.<g> It was up 5.95% at the H at 11:50am and is still up 2.14% at present. Volume of > 5.46M is > its ADV bigcharts.marketwatch.com Yesterday some services were recommending the stock based on the BLOOM trial that was published in the NEJM with an associated editorial.<g> The editorial pointed out that lorcaserin has slightly less than or equal efficacy to Orlistat and slightly less efficacy than Meridia (sibutramine). However, its safety profile appears to be better than that of Xenical (orlistat) or sibutramine and that could justify the approval for lorcaserin. The drug also appears to result in improvement of all surrogate measures of diabetes and cardiovascular risk. Althogh that effect was not very relevant, it is important with the recent problems with rosiglitazone, and since sibutramine did not demonstrated negative cardiovascular outcome in the SCOUT trial. The results of the SCOUT trial were presented at the International Obestity conference in Stockholm. The ACTAY has been increased to $6.15 As mentioned, it seems that the stock could get to test its Feb2009 H at $7.43 or even get to the $10 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next